Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, TGen to Collaborate with NAAR on Autism Research Project

NEW YORK, July 19 (GenomeWeb News) - The National Alliance for Autism Research announced today that it will be collaborating with Affymetrix and the Translational Genomics Research Institute on the first phase of a newly launched study looking for the genes associated with autism.


The project, called the NAAR Autism Genome Project, calls for more than 170 genetics researchers over the next six months to collaborate on scanning the human genome for the genetic roots of autism.


The first phase of the effort, which is already underway, involves two scans of the genome to be conducted by TGen using Affymetrix hardware and equipment, said NAAR. After this first phase is completed, researchers will conduct fine mapping of the chromosomal intervals identified by the scans, followed by further examination of genetic mutations.


Specific terms of NAAR's arrangement with Affymetrix and TGen were not disclosed.


The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.